Clinical and Economic outcomes from Remote Patient Monitoring (RPM)

 With the aim of getting industry buy-in, RPM companies need to generate valuable evidence. However, RPM clinical and economic outcomes can take some time to manifest, plus, measuring and attributing clinical or economic effects to the RPM program can be an arduous task, especially for small companies. Join this meeting to have an informal conversation on:  

 Clinical outcomes: 
-  Level of evidence needed and how does this vary depending on the stakeholder, therapeutic area, region, etc.
- Challenges to build meaningful and trustworthy clinical evidence.
- Best practices and real examples.

 Economic outcomes: 
- How can health systems and payers leverage RPM solutions for disease prevention and management to ultimately reduce healthcare costs?
- Challenges digital health companies face when generating relevant economic evidence to show payers and health systems.